Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 88Recruiting 26Terminated 22Unknown 21Active not recruiting 10Withdrawn 6Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Gynecologic 6Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 369Neoplasms 253Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 192Lung Neoplasms 140Colorectal Neoplasms 137Neoplasm Metastasis 132Pancreatic Neoplasms 131Leukemia, Myeloid, Acute 126Multiple Myeloma 122Lymphoma 114Carcinoma, Hepatocellular 111Ovarian Neoplasms 98Melanoma 97Recurrence 93Leukemia 88Head and Neck Neoplasms 88Leukemia, Lymphocytic, Chronic, B-Cell 86Brain Neoplasms 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Glioblastoma 77Lymphoma, Non-Hodgkin 73Squamous Cell Carcinoma of Head and Neck 71Lymphoma, Follicular 70Lymphoma, Large B-Cell, Diffuse 66Colonic Neoplasms 66Carcinoma, Renal Cell 61Hematologic Neoplasms 59Sarcoma 55Glioma 53

Interventions

niraparib 1dactolisib 1Proflavine 1Office Visits 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Uterine Neoplasms × Clear all
NCT05289648 2024-12-19

NIREC

Sir Mortimer B. Davis - Jewish General Hospital

Phase EARLY_PHASE1 Withdrawn
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04368130 2022-10-14

SIGNAL

Dana-Farber Cancer Institute

Phase NA Withdrawn
Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT03583736 2020-06-30

Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer

Case Comprehensive Cancer Center

Phase NA Withdrawn
Gynecologic

Uterine Neoplasms

NCT01176500 2017-07-02

A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
GastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Uterine Neoplasms

NCT02095847 2015-04-08

High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT01290406 2012-06-21

BEZ235 Trial in Patients With Advanced Endometrial Carcinoma

Novartis

Phase 2 Withdrawn
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡